Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.

Date publication

mai 2019

Journal

Radiation oncology (London, England)

Auteurs

Membres identifiés du Cancéropôle Est :
Dr PREVOST Alain

Tous les auteurs :
Legouté F, Bensadoun RJ, Seegers V, Pointreau Y, Caron D, Lang P, Prévost A, Martin L, Schick U, Morvant B, Capitain O, Calais G, Jadaud E

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31118057

Résumé

Low-level laser therapy (LLLT) also called Photobiomodulation therapy (PBMT) could reduce oral mucositis (OM) incidence and severity in head and neck cancer patients treated by chemoradiotherapy, however randomised data about efficacy and safety are missing with curative dose 4 J/cm.

Mots clés

Chemoradiotherapy, Head and neck cancer, Lasertherapy, Oral mucositis, Supportive care

Référence

Radiat Oncol. 2019 May 22;14(1):83